Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
暂无分享,去创建一个
Ami | D. Rachmilewitz | Hoofnagle Jh | M. Lever | J. caruso | Mcdonald | I. Realdi | A. A | Rugge M Long | Müller Kd | J. B | Rhompson | B. Doran | Webster Adb | Karayiannis P | Jones B
[1] S. Riley,et al. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. , 1988, Gut.
[2] Greenberg Gr,et al. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. , 1988 .
[3] G. Greenberg,et al. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. , 1988, The American journal of gastroenterology.
[4] W. Tremaine,et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.
[5] J. Hardy,et al. Evaluation of an enteric‐coated delayed‐release 5‐aminosalicylic acid tablet in patients with inflammatory bowel disease , 1987, Alimentary pharmacology & therapeutics.
[6] W. Kraaz,et al. Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties. , 1986, Gastroenterology.
[7] I. Donald,et al. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine. , 1985, Postgraduate medical journal.
[8] C. H. Mason,et al. Olsalazine in active ulcerative colitis. , 1985, British medical journal.
[9] C. O'Morain,et al. Reversible male infertility due to sulphasalazine: studies in man and rat. , 1984, Gut.
[10] J. Shaffer,et al. SULPHASALAZINE-INDUCED INFERTILITY REVERSED ON TRANSFER TO 5-AMINOSALICYLIC ACID , 1984, The Lancet.
[11] W. Stenson,et al. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. , 1984, Gastroenterology.
[12] A. Harries,et al. TREATMENT OF ULCERATIVE COLITIS WITH ORAL 5-AMINOSALICYLIC ACID IN PATIENTS UNABLE TO TAKE SULPHASALAZINE , 1983, The Lancet.
[13] K. Das,et al. Sulfasalazine. Adverse effects and desensitization. , 1983, Digestive diseases and sciences.
[14] J. Rhodes,et al. An oral preparation to release drugs in the human colon. , 1982, British journal of clinical pharmacology.
[15] U. Zor,et al. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. , 1981, Gastroenterology.
[16] G. Labó,et al. TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS , 1981, The Lancet.
[17] B. Miller. [Side effects of salicylazosulfapyridine therapy]. , 2008, Deutsche medizinische Wochenschrift.
[18] K Heinkel,et al. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. , 1980, The New England journal of medicine.
[19] J. V. van Tongeren,et al. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. , 1980, Gut.
[20] C. E. Kelly,et al. Hepatotoxicity of salicylazosulfapyridine: a case report and review of the literature. , 1979, The American journal of gastroenterology.
[21] H. Mekhjian,et al. National Cooperative Crohn's Disease Study: adverse reactions to study drugs. , 1979, Gastroenterology.
[22] A. Traub,et al. MALE INFERTILITY DUE TO SULPHASALAZINE , 1979, The Lancet.
[23] A. Levi,et al. MALE INFERTILITY DUE TO SULPHASALAZINE , 1979, The Lancet.
[24] S. Truelove,et al. AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE , 1977, The Lancet.
[25] J. Lennard-jones,et al. Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial. , 1977, Gut.
[26] L. Binderup,et al. Actinomycin D Peritonitis in Rats , 1976 .
[27] R. Pounder,et al. Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. , 1975, Gut.
[28] S. Truelove,et al. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin) , 1973, Gut.
[29] J. McManus,et al. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. , 1973, The New England journal of medicine.
[30] W. Swaim,et al. Azulfidine agranulocytosis with bone marrow, megakaryocytosis, histiocytosis and plasmacytosis. , 1972, Minnesota medicine.
[31] J. Sokal,et al. Sulfapyridine-induced serum-sickness-like syndrome associated with plasmacytosis, lymphocytosis and multiclonal gamma-globulinopathy. , 1969, The New England journal of medicine.
[32] J. Collins. Adverse Reactions to Salicylazosulfapyridine (Azulfidine) in the Treatment of Ulcerative Colitis , 1968, Southern medical journal.
[33] J. H. Baron,et al. CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITIS , 1965 .